Narmada Gelatines Share Price

Narmada Gelatines Limited, with its corporate operations in Jabalpur, functions as a gelatine and allied products manufacturing company in India. The company was incorporated in 1976 and is headquartered in Madhya Pradesh. Narmada Gelatines manufactures high-quality gelatine derived from ossein for pharmaceutical, food, and photographic applications. The company produces edible gelatine, pharmaceutical gelatine, ossein, di-calcium phosphate (DCP), and other by-products. The company operates its manufacturing facility on the banks of the Narmada River and supplies products to domestic and international markets. 

Narmada Gelatines share price on NSE and BSE signifies how market participants react to the company’s operational performance and the overall developments in the specialty chemicals and pharmaceutical ingredients sector. The company’s financial health depends on production volumes, raw material costs including bones and ossein, capacity utilization rates, export demand, and the performance of its gelatine and ossein segments. Narmada Gelatines stock price is influenced by various factors such as earnings, regulatory changes in the pharmaceutical and food industries, global demand for gelatine as a capsule ingredient, and trends in the personal care and nutraceutical sectors. In the longer run, strategies such as expansion into high-value gelatine grades, product portfolio diversification, and value-added product development affect the stock market sentiments. All these factors need to be monitored closely to have an idea about the company’s stock price movements. 

Narmada Gelatines live share price provides real-time information about the last price traded, bid and ask prices, and volume traded. These indicators represent market activity and liquidity, reflecting investor response to corporate announcements, economic conditions, and sector news. Constant monitoring of the Narmada Gelatines live price helps in observing short term price volatility and shows how a stock moves relative to the broader specialty chemicals index. Furthermore, monitoring Narmada Gelatines stock price movements helps investors understand real-time market sentiment, price fluctuations, and trading behaviour. It allows them to evaluate short-term performance, and respond to news, quarterly results, or sector trends that may influence the company’s valuation and overall investment outlook. 

Narmada Gelatines Limited Company Fundamentals 

A. Company Background

Narmada Gelatines Limited was incorporated in 1976 and is engaged in the manufacturing of gelatine and allied products derived from ossein. The company operates primarily in the specialty chemicals and pharmaceutical ingredients segment, supplying products such as edible gelatine, pharmaceutical gelatine, ossein, di-calcium phosphate (DCP), and other by-products for use in capsules, food products, photographic films, and health supplements. Its manufacturing operations are based in India, with a production facility located in Jabalpur, Madhya Pradesh, on the banks of the Narmada River, while corporate functions are managed from its administrative offices in Jabalpur. Over time, the company has expanded its production capacity and product portfolio to serve both domestic and export markets. Financial performance is assessed through standard metrics such as revenue growth, operating margins, and capacity utilisation. Market valuation indicators such as the P/E ratio are used by analysts for comparative assessment within the specialty chemicals sector. Overall fundamentals are influenced by raw material availability (bones), demand from pharmaceutical and food industries, and input cost fluctuations. 

B. Company Product Lines

• Edible Gelatine 

• Manufactures gelatine for food applications including confectionery, desserts, and meat products. 

• Pharmaceutical Gelatine 

• Produces high-quality gelatine for hard and soft capsule manufacturing. 

• Ossein 

• Manufactures ossein (demineralized bone protein) as the raw material for gelatine production. 

• Di-Calcium Phosphate (DCP) 

• Produces DCP as a by-product for use as an animal feed supplement. 

• Bone Chips and By-Products 

• Supplies processed bone chips and other by-products from the manufacturing process. 

C. Company Revenue Model

• Domestic Gelatine Sales 

• Revenue generated through sales of edible and pharmaceutical gelatine to capsule manufacturers, food processors, and pharmaceutical companies across India. 

• Export Sales 

• Contribution from international customers in select global markets for gelatine and by-products. 

• Ossein and DCP Sales 

• Income from sale of ossein to gelatine manufacturers and DCP to animal feed producers. 

• By-Product Sales 

• Revenue from sale of bone chips and other manufacturing by-products. 

Revenue performance is primarily influenced by demand from pharmaceutical capsule manufacturers, food processing industry, raw material availability, and selling price realisations in domestic and export markets. 

D. Geographic Presence

• Corporate and Registered Office 

• Administrative and management functions based in Jabalpur, Madhya Pradesh, India. 

• Manufacturing Facility 

• Production plant located in Jabalpur, Madhya Pradesh, on the banks of the Narmada River. 

• Distribution Network 

• Domestic distribution across India through direct supply to pharmaceutical and food companies. 

• Export Markets 

• Products supplied to select international markets in Europe, Asia, and the Middle East. 

E. Key Milestones

• 1976: Incorporation of Narmada Gelatines Limited. 

• 1992: Listing of equity shares on the Bombay Stock Exchange. 

• 2000s: Expansion of gelatine production capacity. 

• Recent years: Continued focus on quality, export growth, and product innovation. 

F. Industry Perspective

The gelatine and ossein manufacturing industry is capital-intensive and closely linked to demand from pharmaceutical (capsules), food (confectionery, desserts), and photographic industries. Demand trends are influenced by the growth of the nutraceutical and health supplement sectors, as well as the increasing preference for gelatine-based soft capsules. The industry faces fluctuations in raw material prices (animal bones) and compliance with stringent quality standards such as GMP, ISO, and Halal/Kosher certifications. Environmental regulations regarding waste disposal and water treatment are critical operational factors. Companies in this sector must manage raw material sourcing, process efficiency, and regulatory compliance while maintaining product purity and consistency. These factors collectively influence financial performance and investor perception of firms like Narmada Gelatines. 

Narmada Gelatines Limited Stock Market Presence: Listings and Index Representation 

Narmada Gelatines Limited is listed on the National Stock Exchange under the symbol NARMADA and on the Bombay Stock Exchange with the scrip code 526739. Narmada Gelatines share price is actively traded on both exchanges. The company’s market presence is within the small-cap segment of the market. Due to its size and sector focus, Narmada Gelatines stock price is generally tracked by investors interested in the specialty chemicals and pharmaceutical ingredients industry. 

Narmada Gelatines Limited is part of several broad-based and sector-specific stock market indices, reflecting its position as a small-cap specialty chemical company in India. While it is not included in benchmark indices like the Sensex or Nifty 50, it is a constituent of wider market indices such as the BSE SmallCap and BSE Chemicals indices. Narmada Gelatines share price finds representation in these indices based on its market standing. This presence helps investors track the stock relative to other specialty chemical and pharmaceutical ingredient companies. 

Narmada Gelatines Limited Stock Performance and Share Price History 

Narmada Gelatines share price on the stock exchanges reflects its position as a gelatine and ossein manufacturer for pharmaceutical and food applications. Its performance is qualitatively driven by factors such as production capacity utilisation, management of raw material costs including bones, growth in export sales to regulated markets, and the ability to maintain stringent quality standards. Investors compare Narmada Gelatines share price current movement with other specialty chemical and pharmaceutical ingredient companies to assess relative strength. 

These underlying factors become visible through real market movements across different time periods. Similar trends appear during earnings-driven price changes. Broader sector strength has also supported the stock at various points. Beyond operational and sector influences, corporate actions, such as the company’s expansion into high-value pharmaceutical gelatine grades and export market development, have significantly affected Narmada Gelatines share price movements by shaping future growth expectations. This shows how strategic initiatives may trigger short-term swings, even within a regulatory environment influenced by pharmaceutical quality standards and food safety regulations. 

While short-term movements respond to events and announcements, longer-term valuation trends are better captured by Narmada Gelatines share price annual high and low levels, offering context beyond daily or weekly changes. A notable peak indicates strong demand from capsule manufacturers and stable raw material costs, whereas a significant low aligns with market corrections or sector volatility. These extremes reflect the impact of global pharmaceutical demand, regulatory standards, and earnings visibility, providing a framework for understanding historical performance. 

Narmada Gelatines share price behaviour mirrors the trading patterns of a small-cap specialty chemical company within India’s pharmaceutical ingredients ecosystem. The company’s product portfolio spanning edible and pharmaceutical gelatine, ossein, and DCP has shaped its price history. Over the past several years, the stock has experienced periods of sharp gains followed by phases of consolidation. For instance, it delivered positive returns in certain periods when nutraceutical demand increased, but recorded negative returns in other years, underperforming the broader small-cap index over certain horizons. Narmada Gelatines share price has shown moderate to higher volatility at various points. 

The company’s performance has closely tracked pharmaceutical capsule demand and gelatin consumption trends globally. Positive momentum in Narmada Gelatines share price appeared during the post-pandemic period, driven by increased health supplement consumption. However, periods of high raw material costs for bones and competitive pressure from other gelatine manufacturers have led to consolidation in Narmada Gelatines share price. Profitability has shown variability in recent quarters, primarily due to raw material price fluctuations and export demand cycles. 

Despite industry disruptions, Narmada Gelatines shares showed resilience during the recovery phase. While the broader specialty chemicals sector faced supply chain challenges, the company’s established quality certifications and long-standing customer relationships helped the stock recover from fluctuations. The company maintains a manufacturing facility in Jabalpur and continues to focus on export markets. 

Narmada Gelatines share price has declined for several recurring reasons. A drop in demand from pharmaceutical capsule manufacturers directly impacts order volumes and leads to selling pressure. Changes in government policy regarding animal by-product processing or export regulations can also cause the stock to fall. Moreover, increases in operational costs such as bone procurement or energy expenses without matching price increases squeeze margins, making the stock less attractive. Periods of global economic slowdown that affect pharmaceutical and nutraceutical spending raise concerns about export volumes, leading to price declines. Narmada Gelatines share price is sensitive to raw material price movements; if bone prices rise significantly, it can cause the stock to fall as investors adjust expectations for future margin growth. Broader market selloffs in small-cap chemical stocks also pull Narmada Gelatines share price lower, regardless of the company’s individual performance. Lower capacity utilisation or reduced export orders directly hurts revenue, resulting in a lower valuation. 

Narmada Gelatines Limited Investor Relevance and Role in Portfolio 

Narmada Gelatines Limited is a holding in small-cap and specialty chemical portfolios, offering exposure to gelatine and ossein manufacturing for pharmaceutical, food, and nutraceutical applications. Its inclusion in chemical indices underscores its importance in India’s pharmaceutical ingredient supply chain. The company’s position as a manufacturer of high-quality gelatine with a long operating history, together with its export presence and quality certifications, makes it a consideration for long-term allocations. 

Narmada Gelatines share price is influenced by the company’s ownership structure. Narmada Gelatines’ equity is held by a broad mix of promoters, institutional investors, and retail investors, reflecting its standing in India’s specialty chemical sector. Promoters hold a stable majority stake, reflecting strong internal control. Foreign institutional investors hold a modest fraction of the company’s shares. Mutual funds also hold a limited share. The public holds the remaining stake. The company’s management includes named directors as per regulatory filings. This investor base, with stable promoter participation, underscores the company’s role as a holding in both domestic and focused portfolios concentrating on specialty chemicals. 

Beyond fundamentals and ownership, Narmada Gelatines stock price is actively monitored in cash market segments, where trading volumes and delivery patterns reflect expectations on raw material prices, pharmaceutical demand, and regulatory policy actions affecting food and drug ingredients. The stock is available for trading on both major Indian exchanges, allowing investors to take positions based on their outlook for the specialty chemical sector. Market participants watch these trading indicators to gauge sentiment around quarterly results and policy announcements, such as changes in pharmaceutical quality standards. 

Technical indicators provide additional insight into short-term momentum shifts in Narmada Gelatines share price. While these indicators are primarily used for near-term trading decisions, they also help investors and portfolio managers understand broader market sentiment and anticipate potential volatility, especially around key events or announcements. In the short term and weekly timeframe, the stock has exhibited price movements that correlate with broader chemical sector trends. Based on available data, Narmada Gelatines share price beta indicates moderate volatility compared to the broader market. The company’s debt to equity ratio reflects a low use of leverage. Return on equity and return on capital employed are at healthy levels, and the company’s book value per share serves as a reference point for valuation. 

Overall, Narmada Gelatines stock price demonstrates moderate volatility compared to the broader market, with the stock generally considered to have average systematic risk. This makes it moderately sensitive to broader market movements and sector-specific factors such as raw material price fluctuations, pharmaceutical demand cycles, and competition in the gelatine industry. 

Narmada Gelatines Limited Sectoral Relevance and Peer Positioning 

Narmada Gelatines Limited sector relevance stems from its five-decade presence in the gelatine industry, its position as a manufacturer of edible gelatine, pharmaceutical gelatine, ossein, and di-calcium phosphate (DCP) for capsules, food products, and animal feed, its manufacturing facility located in Jabalpur, Madhya Pradesh, its adherence to international quality standards including ISO, GMP, and Halal certifications, its export presence across Europe, Asia, and the Middle East, and its role as a key supplier to pharmaceutical and food processing companies, establishing it as a focused small-cap specialty chemical provider supporting India’s pharmaceutical ingredient ecosystem. Peer comparisons with gelatine and ossein manufacturers like Sterling Biotech, PB Gelatins, Geltech, and other specialty chemical firms in the bio-ingredients space focus on production capacity, product mix, export presence, and value-added product diversification rather than short-term stock moves. These benchmarks help investors assess operational scale, efficiency, and regulatory adherence. Institutional tracking of pharmaceutical demand, raw material availability, and food safety regulations further highlights Narmada Gelatines positioning within India’s broader specialty chemical market. 

Narmada Gelatines P/E ratio reflects how investors perceive the company’s earnings relative to its revenue streams from gelatine, ossein, and DCP sales. Based on available data, the current P/E ratio around 16.86 indicates a certain market perception. The company’s profit after tax has shown growth in certain periods. Quarterly performance has shown sequential movement in some quarters. The company’s earnings before interest and taxes for a recent quarter reflected ongoing operational conditions, and the net profit margin has shown movement in recent quarters. Overall, these changes highlight how market sentiment evolved alongside the company’s operational performance in a cyclical specialty chemical industry. 

Alongside valuation, Narmada Gelatines earnings per share provide insight into the company’s operational performance and income generation from gelatine and by-product sales. Based on available data, the company reported a basic EPS of around Rs 17.30 to Rs 17.58. The trailing twelve-month EPS stands at healthy levels. Narmada Gelatines EPS for the last full fiscal year was higher compared to the prior fiscal year. The company has a face value of Re 1 per share. More recent quarterly performance suggests that EPS has shown responsiveness to cost optimization and improved product mix. 

Narmada Gelatines market cap highlights its position as a small-cap player within India’s specialty chemical sector. Based on recent data, the company’s market capitalization around Rs 250 to Rs 270 crore has moved in line with investor perceptions of its growth potential following its export expansion and product quality enhancements. From earlier years through more recent periods, the market cap showed an increasing trend as the company expanded its export markets and product grades, followed by a significant correction. This pattern reflects investor confidence during favourable pharmaceutical demand cycles, followed by contraction during challenging periods impacted by raw material cost inflation and competitive pressures. This decrease mirrors the correction in Narmada Gelatines share price from its annual high to recent levels. 

Finally, Narmada Gelatines earnings trajectory demonstrates the impact of its operational execution in a competitive specialty chemical industry. In recent fiscal years, total income showed growth supported by the core gelatine business. Based on available data, the company’s revenue from operations increased from the previous fiscal year to the most recent fiscal year. Total income increased over the same period. Profit after tax improved in certain periods. Quarterly performance has shown variability, with total income in a recent quarter rising compared to the previous quarter and also compared to the same quarter of the previous year in some instances. The company’s export sales have contributed significantly to the revenue mix. The company has faced headwinds from fluctuating raw material (bone) prices, competitive pressures from other gelatine manufacturers, and regulatory changes in pharmaceutical ingredient standards. However, the company has expanded into high-value pharmaceutical gelatine grades and expects further growth in the coming periods. These developments illustrate the growth potential of the gelatine industry and the company’s position within this sector. 

Over time, Narmada Gelatines market cap has moved in relation to specialty chemical sector peers. The company’s earnings have followed the pattern typical of ingredient manufacturing businesses, with revenue performance connecting directly to pharmaceutical and food industry demand. Quarterly earnings have shown variability influenced by raw material costs and export order timing. The earnings per share figure has followed the trajectory of overall profitability. The price-to-earnings multiple has varied over time, reflecting changing investor expectations about gelatin demand for capsules and health supplements. When pharmaceutical capsule production increases and raw material costs moderate, the multiple may expand. Conversely, during periods of weak demand or rising bone prices, the multiple may contract. Comparisons with peer specialty chemical companies help investors understand relative valuation. 

Summary 

Narmada Gelatines Limited operates as a small-cap specialty chemical manufacturer with a five-decade operating history, producing gelatine and ossein for pharmaceutical and food applications. Narmada Gelatines share price reflects investor assessment of pharmaceutical demand, raw material cost trends, and export performance. The stock trades on both NSE and BSE within the small-cap segment. Operational performance depends on capsule industry demand and bone prices, while Narmada Gelatines stock price movements are observed by market participants tracking the specialty chemical and pharmaceutical ingredients sector.